Immunovia Reports Promising Accuracy in Clinical Validation of Pancreatic Cancer Detection Test
Immunovia, a leading firm in pancreatic cancer diagnostics, has announced the triumphant completion of its CLARITI study, short for Clinical Validation of Next-Generation Test for Early-Stage Pancreatic Cancer, aimed at identifying early-stage pancreatic ductal adenocarcinoma (PDAC). The study, which analyzed […]